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Abstract
Background Over the past 20 years, the use of clinical
pathways has increased rapidly in many countries. The
implementation of clinical pathways, i.e., using evidence-
based gold standards in diagnostic and treatment algorithms,
is aimed at optimising patient care, improving the intermediate
and discharge outcomes, as well as reducing the inpatient
length of stay and the overall costs. Bulgaria introduced CPs
in 2000, but failed to achieve the goals it had initially set. To
analyse the potential reasons for this failure, our study aims to
describe the approaches used in Bulgaria to develop CPs and
the actual application of CPs in Bulgaria.
Methods We analysed Bulgarian literature and official
government publications and utilised the author’s first-hand
experience, working as a consultant to various governmen-
tal organisations. To evaluate the Bulgarian CPs we
compared the Bulgarian approach with internationally
acknowledged methods to devise CPs.
Results In Bulgaria, the requirements for understanding the
procedures covered by CPs, for defining the rules of
treatment, for monitoring deviations, for refining the rules
and ultimately for modifying practice behaviour have not
been complied with while developing the clinical pathways.
Bulgaria uses CPs as an instrument for resource allocation
to inpatient health-care providers rather than as a tool for
improving health-care quality.
Conclusions Despite the broad scope of discussion in
Bulgaria and the experience and knowledge gained in the
past 5 years, the utilisation of clinical pathways for
improving the quality of medical care is still unsatisfactory.
Bulgarian health decision-makers merely used the title of a
tool with proven qualities in managed care and efficient
resource utilisation without implementing it according to
international standards.




DRG diagnosis related groups
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Background
An increase of health-care expenditure has been observed
in many countries in recent years. At the same time, social
requirements for high quality health services are continu-
ously growing. Therefore, health politicians, funding
institutions and medical professionals develop and intro-
duce strategies for optimisation and efficient spending of
health-care budgets in order to improve the quality of
services provided to the population.
Clinical (or critical) pathways (CPs) have been recog-
nised as an instrument appropriate for this purpose in recent
years (Chou and Boldi 1999).
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In Bulgaria, CPs were first introduced in 2000, at a time
when fundamental health-care reforms were initiated.
Public and medical professionals presumed that upon
the implementation of CPs, diagnostic and therapeutic
guidelines would be established, health-care quality and
outcomes would improve and along with that, resource
utilisation efficiency would rise. In the meantime, health-
care providers and health politicians have determined
that the implementation of CPs in Bulgaria did not fulfil
the envisioned goals. To analyse potential reasons for
that failure, our study describes the Bulgarian model of
CPs and compares the approaches used to develop them
as well as their actual application in Bulgaria to
international standards.
Methods
In order to describe the methods applied for the develop-
ment and the actual application of CPs in Bulgaria, we
analysed existing literature and official government pub-
lications as well as utilised the author’s first-hand experi-
ence, working as a consultant to various governmental
organisations. To evaluate the Bulgarian CPs, we compared
the Bulgarian approach with internationally acknowledged
methods to devise CPs.
Clinical pathways
CPs are management tools, aimed at achieving better
quality and outcomes of care, containing inpatient treatment
costs and increasing health-care efficiency. Chou and Boldy
(1999) defined CPs as “a patient care management plan
developed by a multidisciplinary team for patients with a
particular diagnosis, procedure, or symptom (...). The major
interventions of all disciplines are included in the plan, the
timing and sequencing of care are identified, and an
expected length of stay is determined by the team”.
The potential benefits of using CPs according to key
investigators of the subject (Chou and Boldy 1999; Cheah
2000; Ibarra et al. 1996; Lagoe 1998; Lanska 1998; Ramos
and Ratliff 1997; Smith and Gow 1999) are:
& sustained or improved quality of care
& reduced variation in management practice
& better collaboration and communication between health-
care providers
& lower mortality
& higher patient satisfaction
& improved outcomes
& reduced hospital length of stay (LOS)
& improved health-care efficiency
In order to achieve the indicated outcomes, adherences
to the following steps are recommended when devising
clinical (critical) pathways (Fleischmann et al. 2002):
& Select a topic – generally high volume and high cost
diagnoses and procedures are preferred,
& Select a team – a multidisciplinary approach is crucial
to ensuring support and “buy-in” from the personnel
involved,
& Evaluate current processes of care – a data-driven review
to help identify critical procedures and outcomes,
& Evaluate medical evidence – including the medical
literature as well as internal and external data for
“benchmarking”,
& Select a critical pathway format – simplicity, transpar-
ency and ease of documentation for caregivers are
particularly important in choosing a format,
& Document and analyse variance – choosing which
outcomes and processes to track for assessment,
feedback and iterative improvement.
The health-care reform in Bulgaria
In Bulgaria, CP introduction was one of the major steps in
health-care reform and was associated with the need for a
more efficient management of financial resources.
During the whole period of political, social and
economic transition, which for Central and Eastern Europe
began in 1989, the Bulgarian health-care system has been
reorganised, to some extent, without a clear action plan and
without the needed know-how at the decision-making level.
The new health policy goals have included, amongst others,
high quality of care, improvement of cost efficiency and
patient satisfaction (European Commission and WHO
Regional Office for Europe 2001).
Since 2000, all Bulgarian citizens are subject to a
mandatory insurance plan, covering a specified out- and
inpatient package of medical care benefits defined
annually by the Ministry of Health (MoH) and paid for
by the National Health Insurance Fund (NHIF). Key
feature of the new system are the contracts between
health-care providers and the NHIF. In compliance with
the Health Insurance Act and the Law on the Professional
Associations of the Health-care Providers - Physicians
and Dentists, a National Framework Contract (NFC) is
signed on an annual basis. The signatories are the NHIF,
the Bulgarian Medical Association and the Union of
Dentists in Bulgaria. The most important provisions of
the NFC are the conditions and procedures of choosing
providers with whom the NHIF shall sign an agreement,
the types of services and the volume, prices and method of
payment for in- and outpatient health-care provision.
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Together with the NFC, a trend is established towards
strategic purchasing as a way of allocating resources to
providers in order to maximise fulfilment of the goals for
health system performance. The contracting mechanism
and performance-related payment are used as an instru-
ment for influencing providers’ behaviour and achieving
the health policy objectives.
Clinical pathways in Bulgaria
Until 2000, the health-care system was financed mainly out
of general tax revenues from two main sources – the
national and the municipal budgets. Hospital budgets were
based on the number of patients treated and the number of
bed-days provided. Therefore, they did not reflect the
whole array of in-hospital activities. Hospitals with high
numbers of treated patients and/or high numbers of bed-
days received more money, irrespectively of the provided
medical services. This was one of the key problems that the
health-care reform had to address – ensuring an allocation
of resources to inpatient health-care providers according to
the services actually provided.
As of 2001, the NHIF began paying for inpatient care on
the basis of clinical pathways. While in 2001, the NHIF
paid for only 21 CPs (National Framework Contract 2001),
this number rose to 30 CPs in 2002 (National Framework
Contract 2002), 81 CPs (National Framework Contract
2003) in the years 2003-2004, and to 120 CPs (National
Framework Contract 2005) in 2005. For treatment of
patients with diagnoses not included in CPs, the hospitals
received funds from the MoH based on past budgets. As of
2006, inpatient care in Bulgaria was financed completely
by the NHIF. The NHIF currently pays for treatment under
290 CPs, which cover about 7,600 types of diseases
(National Framework Contract 2006). According to pre-
liminary estimates, there are six diseases representing the
most common causes of hospitalisation (Bucarev 2005).
In Bulgaria, the NFC of 2001 (National Framework
Contract 2001) defined the clinical pathways primarily as an
integrated approach for behaviour modelling of various
medical professionals in the treatment of patients with
specified health problems and secondly as a quality manage-
ment tool. Key elements of the CPs are guidelines for:
& the general practitioner and/or the outpatient care
specialist whose job it is to prepare the patient for
hospitalisation,
& the hospital diagnosis,
& the consulting specialist with specific hospitalisation
indications,
& the hospital medical devices, structural units and staff
qualification,
& the clinical behaviour of the medical staff in hospitals,
& the amount paid for treatment according to the
respective CP,
& the length of stay.
Evaluation of Bulgarian CPs
By comparing the key steps for devising CPs mentioned
above and the approach towards developing CPs in
Bulgaria, we can identify the following essential differences
between the international standard model for CPs and the
Bulgarian model.
Select a topic
Generally, CPs are developed and implemented for patients
suffering from specific diseases, associated with a high risk
or generally leading to severe complications, the treatment
of which is generally expensive, consumes extensive
resources or demands prolonged length of stay in the
hospital (Fleischmann et al. 2002; Ibarra et al. 1996; Ramos
and Ratliff 1997; Schriefer et al. 2000).
Due to the fact that in Bulgaria CPs are predominantly a
financial instrument with the intention to cover the greatest
possible number of hospitalisation causes, the Bulgarian
CPs include more than 7,000 diseases and conditions, but
naturally not all of these are associated with a high
consumption of resources, prolonged LOS or a high risk
for the patient.
Select a team
Generally, a multidisciplinary team should be charged with
defining the major interventions, such as diagnosis, treatment,
medication and discharge planning, as well as the right
sequence and timing in order to achieve the best possible
intermediate and discharge outcomes for particular types of
cases using the best available research evidence and clinical
guidelines (Fleischmann et al. 2002; Kaltenthaler et al. 2001;
Klenner 2000; Leininger 1996; Little and Whipple 1996;
Lynn 1996). Participation of representatives from different
clinical specialties as well as from related disciplines in the
multidisciplinary team contributes to the practicality of the
pathway and ensures acceptance and support for its
implementation (Fleischmann et al. 2002).
In Bulgaria, however, CPs were developed exclusively
by specialists of a given area. Representatives of other
clinical specialties taking part in the treatment or other
medical staff were generally not included in the team. This
“monodisciplinary” approach to the development of CPs is
probably the cause for the absence of exact timing and
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sequencing of activities and for insufficient support
amongst medical professionals in the hospitals.
Evaluate current processes of care
This step is intended to facilitate the detection and analysis
of the current variation in health-care processes. A thorough
review of medical inpatient records is necessary to identify
the outcomes and high-cost areas (Every et al. 2000). The
evaluation of existing processes of care is generally performed
for the purpose of optimising them wherever possible by
introducing CPs, with the aim of changing medical staff
behaviour, shortening the LOS and reducing costs.
In Bulgaria, this step was generally skipped during the
development of CPs. As mentioned above, Bulgarian CPs
were developed by specialists of a given area who work in
university clinics and highly specialised hospitals. There-
fore, they were familiar only with the processes in such
facilities. In general, assessment and situational analysis of
existing processes of care in regional or municipal hospitals
were not taken into account. Recommendations were
drafted mainly based on literature data while disregarding
available field data from Bulgarian hospitals.
To give an example, the average length of stay was
estimated according to data provided by American and
Western European authors. This led to the fixed LOS being
shorter than the usual LOS for these diseases in Bulgaria.
Regardless, this fixed LOS is currently mandatory for the
providers according to the NFC.
The Bulgarian set of CPs therefore defines an unrealis-
tically low fixed LOS. Thus, one of the ultimate goals of
the health-care reform, shortening the average LOS, was
instituted as a prerequisite for meeting the new guidelines
without first acquiring sufficient evidence from existing
practice that shortening the LOS was medically justified in
all instances. A proper analysis of re-hospitalisations and
intermediate- and long-term outcomes for the same disease
has not been undertaken, nor has the level of readiness of
outpatient services to provide care for patients discharged
prematurely been sufficiently studied.
Evaluate medical evidence
According to the guidelines for defining CPs, a compre-
hensive literature review should be the first step in this
process. Data on best practices should be collected in order
to define the best possible processes of care to be included
in clinical guidelines.
Clinical guidelines are systematically developed state-
ments aimed at assisting decision-making regarding appro-
priate health-care interventions in specific clinical
circumstances. Guidelines can be linked in order to form
CPs or algorithms of typical cases (Grundmann 2000). The
philosophy underlying the application of clinical guidelines
is to improve the quality of outcome by raising the quality
of the individual intermediate diagnostic and therapeutic
processes.
If we look more closely at the algorithm definition
given by Banks (1996), the “clinical algorithm” is a set of
rules or instructions leading to the solution of a defined
medical problem whose implementation depends on
specific conditions.
Algorithms are designed on the basis of a decision-node
logic for defining the next CP step for the respective
condition or disease, age, sex, co-morbidity and complica-
tion. Each algorithm is designed solely for a single specific
function. Examples include pharmacological treatment
algorithms, surgical treatment algorithms or complication
management algorithms. An algorithm offers only one
solution in specific circumstances. In other words, if a
condition is met, then an exactly predefined decision-
behaviour follows under the given circumstances. This is an
“if – then” algorithm.
The algorithm of the “90-min accelerated critical
pathway for chest pain evaluation”, developed and applied
by the University Department of San Diego, California, can
be used for a more exact illustration of the aforementioned
(Ng et al. 2001). This algorithm defines the steps by which
the nature of chest pain and its subsequent aetiology-based
treatment can be evaluated within 90 min, making use of
certain clinical and biochemical indicators. The chest pain
early diagnosis CP is followed by other clinical pathways
for further treatment.
In Bulgaria, neither clinical guidelines nor clinical algo-
rithms were successfully integrated into most of the CPs. This
occurred primarily because only a few clinical guidelines had
been introduced in Bulgaria when CPs were implemented.
Secondly, over 80% of the Bulgarian CPs are a combination of
similar diagnoses and conditions. Like the diagnosis related
groups (DRGs) for patients differing in their medical and
biological characteristics, they are rather broad in scope and
therefore cannot contain a clinical algorithm as an option for
solving a particular problem, but rather offer a range of
possible diagnostic and therapeutic strategies. Incorporating
multiple diagnoses, conditions and critical procedures into one
CP, parallel to the DRGs, impedes the implementation of
clinical guidelines and clinical algorithms.
Determine the critical pathway format
Usually the CPs represent a scheme of procedures and a
sequence of actions (Asadi and Baltz 1996). There are
different solutions for including the clinical pathway in the
in-patient record. It could be a part of the medical record
or a separate file as a documentation tool (Little and
Whipple 1996).
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In Bulgaria, record keeping of processes has been
subject to continuous changes during the past 5 years.
While the hope is to find the best solution in this regard,
results are still unsatisfactory. The NHIF reviews indicate
that the most common infringements were associated with
documenting treatment according to CPs - 42% of all
identified infringements in 2004 and 45.3% in 2005
(National Health Insurance Fond 2004, 2005).
Document and analyse variance
A key issue related to the use of CPs in hospital practice is
the influence of deviation from established standards on
intermediate and discharge outcomes. Some authors rec-
ommend documenting the variance from CPs (Little and
Whipple 1996; Every et al. 2000). Variance is defined as
the difference between the planned process for a homoge-
neous patient group and the differences identified in
individual members of this group (Leininger 1996). If
variance influences outcomes in a negative direction, the
specific causes should be identified and eliminated.
In the case of deviation in a positive direction, the
phenomenon should be investigated by analysing the
activities that had positive impact on the patient’s condition
for eventual future incorporation in CPs.
Until 2005, instances of deviation were recorded and
analysed in Bulgaria in rather general terms, mainly due to
problems associated with the documentation format, the
annual introduction of new CPs and the lack of data-
processing capacity both in the hospitals and in the NHIF.
They have not been documented thereafter.
In addition, the use of CPs must be safe for the patients.
Therefore, piloting every CP is recommended prior to its
general introduction by monitoring its intermediate and
long-term outcomes (Fleischmann et al. 2002).
In Bulgaria, CP monitoring has never been undertaken
regardless of the existing assumptions that treatment under
certain CPs leads to long-term outcomes that do not differ
significantly from previous practice. Likewise, patient
satisfaction with the received treatment, which is an
important feedback for ongoing quality improvement (Chou
and Boldy 1999), has not been studied.
Clinical pathways as a financial tool
As mentioned above, CPs are also used as a financial tool
in the Bulgarian health-care setting. Any medical activity
requires certain financial and human resources. The
accurate estimate of all resources necessary for treatment
of a particular diagnosis or CP may provide a clear picture
of costs and show which clinical activities are consuming
substantial resources. Some authors (Asadi and Baltz 1996)
recommend the integration of activity-based costing (ABC)
to CPs as a financial tool. The ABC tool enables health-care
decision-makers to explore the kind and quantity of
resources needed for a given treatment, to determine how
to allocate resources efficiently and to examine if the
provided CPs are profitable.
In Bulgaria, the amount paid for treatment by the NHIF
according to the CPs can hardly cover the actually incurred
costs. The resources spent for specific crucial activities, the
prices of the administered drugs and consumables as well as
staff salaries were not taken into account when estimating
the CP remuneration. For CP no. 54, the “acute coronary
syndrome with persistent ST-elevation and thrombolysis”,
the NHIF pays 1,176 euros (National Framework Contract
2005) per hospital stay, for example. However, the price at
which the hospitals buy the most commonly marketed drug
Actilyse is 869.00 euros for 20 mg powd. inj. The more
expensive and thus rarely used Rapilysin costs 1,023 euros
for 2×10 U. This means that hospitals performing
thrombolysis are not able to cover their costs. Due to such
“deficient financing” of CPs, physicians face limitations in
decision-making. In the example cited above, thrombolysis
in acute coronary syndrome with persistent ST elevation is
applied relatively rarely in Bulgaria.
CPs could be applicable in health systems with different
financing principles, including defined budget or state
subsidies (Cheah 2000; Ramos and Ratliff 1997). In
countries with limited financial resources, they may assist
in the efficient use of limited funds without compromising
the quality of care (Cheah 2000). In Bulgaria, health-care
funds are rather limited. For the past 7 years, the government
allocated an average of 4.2% of the GDP to health care.
According to the current Bulgarian legislation, CP prices are
fixed annually, i.e., there is a defined inpatient care budget
per CP. In 2007, the MoH realised that in 75% of the cases,
the amounts allocated for CPs covered only up to 60% of the
actual costs (Ministry of Health 2007). Additionally, some
authors (Cheah 2000) speculate that while the costs in the
hospital sector are decreasing due to optimised processes and
a shorter LOS, the costs for follow-up treatment may be
increasing. Since there is only insufficient information on
this matter, it is impossible to determine whether the
Bulgarian CPs are able to increase efficient use of health-
care resources. Similarly, it is impossible to estimate the
impact of CPs on the overall cost-effectiveness of the health-
care system or on the society.
Conclusions
The introduction of CPs in Bulgaria aimed at improving the
quality of health services and optimising health-care costs.
However, the providers and the public soon identified
negative aspects as well, which did not ensue from the CPs
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themselves but rather from their incorrect development,
introduction and implementation.
Regarding the Bulgarian set of CPs, it may be stated that
they have been designed according to literature data and
experience from other countries and have been imposed
administratively as a tool for containing health-care costs
on a national level. The essential and internationally
recognised steps for the design and implementation of
CPs have not been complied with. The Bulgarian CPs offer
general solutions to health-care problems, which are most
frequently not in line with local capacity and without
defining the sequence of clinical procedures. In general
terms, the requirements for “understanding the procedures
involved in providing care, defining the rules of care,
monitoring deviations from the rules and ultimately refining
the rules and modifying practice behaviour” (Little and
Whipple 1996) have not been complied with while
developing the CPs in Bulgaria.
Furthermore, there is no capacity in the hospitals for
collecting and analysing data on processes and outcomes of
care and on their variance between providers, especially for
non-surgical CPs. The evaluation of medical and financial
outcomes on both the hospital and the national level is an
issue of the indefinite future.
Despite the broad scope of discussion in Bulgaria and
the experience and knowledge gained in the past 5 years,
the utilisation of CPs for improving the quality of medical
care is still unsatisfactory. Bulgarian health decision-makers
only used the title of a tool with proven qualities in
managed care and efficient resource utilisation without
implementing it according to international standards.
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